<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report ( Date of earliest reported) January 3, 2000
---------------
BIOQUAL, Inc.
-------------
(Exact name of registrant as specified in its chapter)
State of Delaware 1-13527 13-33078199
----------------- ------- -----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
9600 Medical Center Drive, Rockville, Maryland 20850
- ---------------------------------------------- -----
address of principal executive office (zip code)
Registrant's telephone number, including area code (301) 251-2801
--------------
Diagnon Corporation
-------------------
(Former name, the name has changed since last report)
-----------------------------------------------------
<PAGE>
Item 5. Other Events
The registrant has issued the attached Release to be filed on January
3, 2000.
Exhibit:
(1) Diagnon Corporation Changes Its Name to BIOQUAL, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BIOQUAL, Inc.
By /s/ John C. Landon
------------------
Chairman of the Board,
President and Chief Executive
Officer
Date: January 3, 2000
<PAGE>
Exhibit 99
BIOQUAL, Inc.
- -------------------------------------------------------------------------------
"NEWS RELEASE"
FOR RELEASE: January 3, 2000, Rockville, MD
CONTACT: John C. Landon, Ph.D., President (301 251 2801)
DIAGNON CORPORATION CHANGES ITS NAME TO BIOQUAL, INC.
On January 1, 2000, Diagnon Corporation (BIQL-OTC, DNG-CHX) changed its name to
BIOQUAL, Inc. (BIQL-OTC, BQI-CHX). The name change was effected as a result of
the merger of Diagnon and its wholly-owned subsidiary BIOQUAL, Inc., with
Diagnon being the surviving corporation. In the merger however, Diagnon adopted
the name BIOQUAL, Inc., as the name of the surviving corporation. The business
and operations of BIOQUAL, Inc. will be the same as the consolidated business
and operations of Diagnon together with its wholly-owned subsidiaries prior to
the merger.
"Our new name better reflects the Company's focus of providing a broad spectrum
of basic, developmental, and applied research in the human and veterinary
medical fields," said John C. Landon, Ph.D., President and Chief Executive
Officer.
